logo
  

BMY : Canada Approves OPDIVO For Treatment Of Certain Patients Diagnosed With Urothelial Cancer

Bristol Myers Squibb Canada said Health Canada has issued a Notice of Compliance with Conditions for OPDIVO, as a monotherapy for the adjuvant treatment of adult patients with urothelial carcinoma (UC) who are at high risk of recurrence after undergoing radical resection of urothelial carcinoma.

OPDIVO is the first immuno-oncology treatment to bring benefit in the adjuvant setting of urothelial carcinoma and represents a potential new standard of care for patients at high risk of disease recurrence.

Bladder cancer begins when healthy cells in the bladder lining—most commonly urothelial cells—change and grow out of control, forming a mass called a tumor. Urothelial cells also line the renal pelvis and ureters. Cancer that develops in the renal pelvis and ureters is also considered a type of urothelial cancer and is referred to upper tract urothelial carcinoma (UTUC).

Urothelial carcinoma of the bladder (UCB) is the most common malignancy of the urinary tract, and the fifth most common cancer in Canada.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Centers for Disease Control and Prevention or CDC director, Rochelle Walensky, has initiated a reorganization of the public health agency noting that it failed to reliably meet expectations during the coronavirus pandemic period, reports said. The proposed changes for a reset in the agency are expected to help it respond quicker to new health threats. While reporting financial results for the second quarter on Thursday, department store chain Kohl's Corp. (KSS) slashed its adjusted earnings and sales growth guidance for the full-year 2022. For fiscal 2022, the company now projects adjusted earnings in a range of $2.80 to $3.20 per share on a net... Apple Inc. is planning to hold a launch event on September 7 to unveil its latest iPhone 14 line, Bloomberg reported citing people with knowledge of the matter. The tech major is also expected to roll out its latest version of three Apple Watch models including Series 8. The new products, which also include multiple new versions of Macs, and low and high-end iPads, are likely to reach stores...
Follow RTT